Nature Communications,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: Jan. 2, 2025
Bacteria
of
clinical
importance,
such
as
Pseudomonas
aeruginosa,
can
become
hypermutators
upon
loss
DNA
mismatch
repair
(MMR)
and
are
clinically
correlated
with
high
rates
multidrug
resistance
(MDR).
Here,
we
demonstrate
that
hypermutated
MMR-deficient
P.
aeruginosa
has
a
unique
mutational
signature
rapidly
acquires
MDR
repeated
exposure
to
first-line
or
last-resort
antibiotics.
acquisition
was
irrespective
drug
class
instead
arose
through
common
mechanisms
shared
between
the
initial
secondary
drugs.
Rational
combinations
drugs
having
distinct
prevented
in
aeruginosa.
Mutational
analysis
across
different
human
disease
contexts
identified
appreciable
quantities
isolates
were
already
prone
future
acquisition.
patient
samples
is
promising
diagnostic
tool
may
predict
guide
precision-based
medical
care.
identifies
hypermutator
strains
prognostically
predicts
acquisiton,
potentially
serving
effective
personalized
treatment.
Cell,
Journal Year:
2024,
Volume and Issue:
187(9), P. 2324 - 2335.e19
Published: April 1, 2024
Microbial
communities
are
resident
to
multiple
niches
of
the
human
body
and
important
modulators
host
immune
system
responses
anticancer
therapies.
Recent
studies
have
shown
that
complex
microbial
present
within
primary
tumors.
To
investigate
presence
relevance
microbiome
in
metastases,
we
integrated
mapping
assembly-based
metagenomics,
genomics,
transcriptomics,
clinical
data
4,160
metastatic
tumor
biopsies.
We
identified
organ-specific
tropisms
microbes,
enrichments
anaerobic
bacteria
hypoxic
tumors,
associations
between
diversity
tumor-infiltrating
neutrophils,
association
Fusobacterium
with
resistance
checkpoint
blockade
(ICB)
lung
cancer.
Furthermore,
longitudinal
sampling
revealed
temporal
evolution
depleted
upon
ICB.
Together,
generated
a
pan-cancer
resource
may
contribute
advancing
treatment
strategies.
Nature,
Journal Year:
2023,
Volume and Issue:
620(7974), P. 607 - 614
Published: July 26, 2023
Recent
studies
have
documented
frequent
evolution
of
clones
carrying
common
cancer
mutations
in
apparently
normal
tissues,
which
are
implicated
development1-3.
However,
our
knowledge
is
still
missing
with
regard
to
what
additional
driver
events
take
place
order,
before
one
or
more
these
tissues
ultimately
evolve
cancer.
Here,
using
phylogenetic
analyses
multiple
microdissected
samples
from
both
and
non-cancer
lesions,
we
show
unique
evolutionary
histories
breast
cancers
harbouring
der(1;16),
a
alteration
found
roughly
20%
cancers.
The
approximate
timing
early
was
estimated
the
mutation
rate
measured
epithelial
cells.
In
der(1;16)(+)
cancers,
derivative
chromosome
acquired
puberty
late
adolescence,
followed
by
emergence
ancestor
patient's
30s,
evolved.
Replacing
pre-existing
mammary
epithelium
following
years,
occupied
large
area
within
premenopausal
time
diagnosis.
Evolution
independent
founders
ancestors
common,
contributing
intratumour
heterogeneity.
number
did
not
correlate
histology,
suggesting
role
local
microenvironments
and/or
epigenetic
events.
A
similar
pattern
also
observed
another
case
evolving
an
AKT1-mutated
founder.
Taken
together,
findings
provide
new
insight
into
how
evolves.
Bioinformatics,
Journal Year:
2023,
Volume and Issue:
39(12)
Published: Dec. 1, 2023
Analysis
of
mutational
signatures
is
a
powerful
approach
for
understanding
the
mutagenic
processes
that
have
shaped
evolution
cancer
genome.
To
evaluate
operative
in
genome,
one
first
needs
to
quantify
their
activities
by
estimating
number
mutations
imprinted
each
signature.
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: Aug. 28, 2023
Abstract
The
zoonotic
origin
of
the
COVID-19
pandemic
virus
highlights
need
to
fill
vast
gaps
in
our
knowledge
SARS-CoV-2
ecology
and
evolution
non-human
hosts.
Here,
we
detected
that
was
introduced
from
humans
into
white-tailed
deer
more
than
30
times
Ohio,
USA
during
November
2021-March
2022.
Subsequently,
deer-to-deer
transmission
persisted
for
2–8
months,
disseminating
across
hundreds
kilometers.
Newly
developed
Bayesian
phylogenetic
methods
quantified
how
is
not
only
three-times
faster
compared
rate
observed
but
also
driven
by
different
mutational
biases
selection
pressures.
long-term
effect
this
accelerated
evolutionary
remains
be
seen
as
no
critical
phenotypic
changes
were
animal
models
using
viruses.
Still,
has
transmitted
populations
a
relatively
short
duration,
risk
future
may
have
serious
consequences
livestock.
Cancer Cell,
Journal Year:
2024,
Volume and Issue:
42(3), P. 487 - 496.e6
Published: March 1, 2024
Co-culture
of
intestinal
organoids
with
a
colibactin-producing
pks+
E.
coli
strain
(EcC)
revealed
mutational
signatures
also
found
in
colorectal
cancer
(CRC).
Nissle
1917
(EcN)
remains
commonly
used
probiotic,
despite
harboring
the
pks
operon
and
inducing
double
strand
DNA
breaks.
We
determine
mutagenicity
EcN
three
CRC-derived
strains
an
analytical
framework
based
on
sequence
characteristic
colibactin-induced
mutations.
All
strains,
including
EcN,
display
varying
levels
mutagenic
activity.
Furthermore,
machine
learning
approach
attributing
individual
mutations
to
colibactin
reveals
that
patients
are
diagnosed
at
younger
age
can
induce
specific
APC
mutation.
These
approaches
allow
sensitive
detection
∼12%
CRC
genomes
even
whole
exome
sequencing
data,
representing
crucial
step
toward
pinpointing
activity
distinct
strains.
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: April 20, 2023
Abstract
Amyotrophic
Lateral
Sclerosis
(ALS)
causes
motor
neuron
degeneration,
with
97%
of
cases
exhibiting
TDP-43
proteinopathy.
Elucidating
pathomechanisms
has
been
hampered
by
disease
heterogeneity
and
difficulties
accessing
neurons.
Human
induced
pluripotent
stem
cell-derived
neurons
(iPSMNs)
offer
a
solution;
however,
studies
have
typically
limited
to
underpowered
cohorts.
Here,
we
present
comprehensive
compendium
429
iPSMNs
from
15
datasets,
271
post-mortem
spinal
cord
samples.
Using
reproducible
bioinformatic
workflows,
identify
robust
upregulation
p53
signalling
in
ALS
both
cord.
activation
is
greatest
C9orf72
repeat
expansions
but
weakest
SOD1
FUS
mutations.
depletion
potentiates
neuronal
nuclei
cell
culture,
thereby
functionally
linking
depletion.
tissue
display
enrichment
splicing
alterations,
somatic
mutations,
gene
fusions,
possibly
contributing
the
DNA
damage
response.
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: May 4, 2023
Abstract
Xeroderma
pigmentosum
(XP)
is
a
genetic
disorder
caused
by
mutations
in
genes
of
the
Nucleotide
Excision
Repair
(NER)
pathway
(groups
A-G)
or
Translesion
Synthesis
DNA
polymerase
η
(V).
XP
associated
with
an
increased
skin
cancer
risk,
reaching,
for
some
groups,
several
thousand-fold
compared
to
general
population.
Here,
we
analyze
38
genomes
from
five
groups.
We
find
that
activity
NER
determines
heterogeneity
mutation
rates
across
and
transcription-coupled
extends
beyond
gene
boundaries
reducing
intergenic
rate.
Mutational
profile
XP-V
tumors
experiments
POLH
knockout
cell
line
reveal
role
error-free
bypass
(i)
rare
TpG
TpA
lesions,
(ii)
3’
nucleotides
pyrimidine
dimers,
(iii)
TpT
photodimers.
Our
study
unravels
basis
risk
provides
insights
into
mechanisms
UV-induced
mutagenesis
Nature Genetics,
Journal Year:
2023,
Volume and Issue:
56(1), P. 23 - 26
Published: Nov. 30, 2023
Abstract
The
chemotherapeutic
agent
CX-5461,
or
pidnarulex,
has
been
fast-tracked
by
the
United
States
Food
and
Drug
Administration
for
early-stage
clinical
studies
of
BRCA1-
,
BRCA2-
PALB2
-mutated
cancers.
It
is
under
investigation
in
phase
I
II
trials.
Here,
we
find
that,
although
CX-5461
exhibits
synthetic
lethality
BRCA1-/BRCA2
-deficient
cells,
it
also
causes
extensive,
nonselective,
collateral
mutagenesis
all
three
cell
lines
tested,
to
magnitudes
that
exceed
known
environmental
carcinogens.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: March 18, 2024
Abstract
The
APOBEC3
enzymes
convert
cytosines
in
single-stranded
DNA
to
uracils
protect
against
viruses
and
retrotransposons
but
can
contribute
mutations
that
diversify
tumors.
To
understand
the
mechanism
of
mutagenesis,
we
map
resulting
from
expression
APOBEC3B
or
its
catalytic
carboxy-terminal
domain
(CTD)
Escherichia
coli
.
Like
APOBEC3A,
uracilomes
A3B
A3B-CTD
show
a
preference
deaminate
near
transcription
start
sites
lagging-strand
replication
templates
hairpin
loops.
Both
biochemical
activities
genomic
uracil
distribution
A3A
prefers
3
nt
loops
best,
while
4
Reanalysis
loop
human
tumors
finds
intrinsic
characteristics
both
enzymes,
with
much
stronger
contribution
A3A.
We
apply
Hairpin
Signatures
1
2,
which
define
preferences
respectively
are
orthogonal
published
methods,
evaluate
their
tumor
mutations.